RxDoctor Payments Data

Borys Krynyckyi, MD

Nuclear Medicine · Galloway, NJNPI 1003892613

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Sanofi at 28.8% of the total. Reporting peaked in 2019 at $227 and has fallen 79.5% since, to $47 in 2025.

$385in general payments, 2019–2025

Across 7 payments — averaging $54.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$111
  • Blue Earth Diagnostics$98
  • GE HealthCare$78
  • Astellas Pharma US Inc$51
  • Telix Pharmaceuticals$32
  • Progenics Pharmaceuticals, Inc.$15

What the payments were for

  • Food & beverage$385100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,734,936
Medicare patients
724
Services billed
2,993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in Galloway

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →